Zynex (ZYXI) Competitors

Zynex (NASDAQ:ZYXI) and Neuronetics (NASDAQ:STIM) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, valuation, profitability, media sentiment, analyst recommendations, earnings, institutional ownership and dividends.

Which has more risk & volatility, ZYXI or STIM?

Zynex has a beta of 0.7, suggesting that its share price is 30% less volatile than the S&P 500. Comparatively, Neuronetics has a beta of 1.92, suggesting that its share price is 92% more volatile than the S&P 500.

Do analysts rate ZYXI or STIM?

Zynex presently has a consensus target price of $6.00, indicating a potential upside of 160.87%. Neuronetics has a consensus target price of $5.50, indicating a potential upside of 37.29%. Given Zynex's higher possible upside, analysts plainly believe Zynex is more favorable than Neuronetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zynex	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Neuronetics	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Does the media prefer ZYXI or STIM?

In the previous week, Zynex had 26 more articles in the media than Neuronetics. MarketBeat recorded 29 mentions for Zynex and 3 mentions for Neuronetics. Neuronetics' average media sentiment score of 0.39 beat Zynex's score of 0.01 indicating that Neuronetics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zynex	0 Very Positive mention(s)	5 Positive mention(s)	22 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Neuronetics	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has preferable earnings and valuation, ZYXI or STIM?

Zynex has higher revenue and earnings than Neuronetics. Zynex is trading at a lower price-to-earnings ratio than Neuronetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zynex	$172.40M	0.40	$9.73M	-$0.24	-9.58
Neuronetics	$89.45M	2.95	-$30.19M	-$1.31	-3.06

Do insiders & institutionals have more ownership in ZYXI or STIM?

29.7% of Zynex shares are owned by institutional investors. Comparatively, 53.6% of Neuronetics shares are owned by institutional investors. 49.3% of Zynex shares are owned by company insiders. Comparatively, 8.7% of Neuronetics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Is ZYXI or STIM more profitable?

Zynex has a net margin of 2.49% compared to Neuronetics' net margin of -50.09%. Zynex's return on equity of 13.05% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zynex	2.49%	13.05%	3.78%
Neuronetics	-50.09%	-141.24%	-32.77%

Does the MarketBeat Community prefer ZYXI or STIM?

Neuronetics received 98 more outperform votes than Zynex when rated by MarketBeat users. Likewise, 68.62% of users gave Neuronetics an outperform vote while only 55.36% of users gave Zynex an outperform vote.

Company	Underperform	Outperform
Zynex	Outperform Votes 31 55.36%	Underperform Votes 25 44.64%
Neuronetics	Outperform Votes 129 68.62%	Underperform Votes 59 31.38%

Summary

Zynex beats Neuronetics on 10 of the 18 factors compared between the two stocks.